Nova Patents
IL233192B

Ph20 polypeptide variants, formulations and uses thereof

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

107 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
201161631313United States of AmericaP
201261796208United States of AmericaP
2012072182United States of AmericaW

Members107

Family members, oldest first
DocumentOfficeKind
CA2861919A1CanadaA1
WO2013102144A2World Intellectual Property Organization (WIPO)A2
WO2013102144A8World Intellectual Property Organization (WIPO)A8
US2013302275A1United States of AmericaA1
WO2013102144A3World Intellectual Property Organization (WIPO)A3
US2014178330A9United States of AmericaA9
AU2012362141A1AustraliaA1
SG11201403714TASingaporeA
IL233192A0IsraelA0
IL233192D0IsraelD0
MX2014007966AMexicoA
EP2797622A2European Patent Office (EPO)A2
CN104244968AChinaA
JP2015504666AJapanA
EA201400772A1Eurasian Patent Organization (EAPO)A1
HK1202814AHong Kong, ChinaA
HK1202814A1Hong Kong, ChinaA1
NZ626126ANew ZealandA
SG10201604470TASingaporeA
US9447401B2United States of AmericaB2
EP2797622B1European Patent Office (EPO)B1
US2016362670A1United States of AmericaA1
DK2797622T3DenmarkT3
JP6067746B2JapanB2
EP3130347A1European Patent Office (EPO)A1
ES2609582T3SpainT3
JP2017112999AJapanA
CN104244968BChinaB
AU2012362141B2AustraliaB2
AU2017245352A1AustraliaA1
EA030252B1Eurasian Patent Organization (EAPO)B1
JP6422933B2JapanB2
MX361727BMexicoB
CA2861919CCanadaC
AU2017245352B2AustraliaB2
EP3130347B1European Patent Office (EPO)B1
DK3130347T3DenmarkT3
LT3130347TLithuaniaT
PT3130347TPortugalT
SMT201900630T1San MarinoT1
RS59703B1SerbiaB1
SI3130347T1SloveniaT1
HRP20192249T1CroatiaT1
ES2749620T3SpainT3
NZ720075ANew ZealandA
PL3130347T3PolandT3
HUE047849T2HungaryT2
IL233192AIsraelA
IL233192BThis recordIsraelB
IL274798D0IsraelD0
US2020255814A1United States of AmericaA1
MX2018012394AMexicoA
US2020318091A1United States of AmericaA1
BR112014016195A2BrazilA2
US10865400B2United States of AmericaB2
CY1122532T1CyprusT1
IL274798AIsraelA
IL274798BIsraelB
IL280949AIsraelA
IL280949D0IsraelD0
US11041149B2United States of AmericaB2
US11066656B2United States of AmericaB2
EA030252B9Eurasian Patent Organization (EAPO)B9
US2021277376A1United States of AmericaA1
US2021284985A1United States of AmericaA1
IL280949BIsraelB
IL298330AIsraelA
IL280949B2IsraelB2
US2023151346A1United States of AmericaA1
US2023212547A1United States of AmericaA1
US2023250409A1United States of AmericaA1
US2023287381A1United States of AmericaA1
US2023295592A1United States of AmericaA1
US2023295593A1United States of AmericaA1
US2023357739A1United States of AmericaA1
US2024002825A1United States of AmericaA1
US2024002826A1United States of AmericaA1
US2024011008A1United States of AmericaA1
US2024026327A1United States of AmericaA1
US2024026328A1United States of AmericaA1
US11952600B2United States of AmericaB2
US12018298B2United States of AmericaB2
US2024209337A1United States of AmericaA1
US12037618B2United States of AmericaB2
US12049652B2United States of AmericaB2
US12054758B2United States of AmericaB2
US12060590B2United States of AmericaB2
US12077791B2United States of AmericaB2
US12091692B2United States of AmericaB2
US2024318158A1United States of AmericaA1
US12104184B2United States of AmericaB2
US12104185B2United States of AmericaB2
US12110520B2United States of AmericaB2
US12123035B2United States of AmericaB2
US12152262B2United States of AmericaB2
IL317266AIsraelA
US12195773B2United States of AmericaB2
US2025051747A1United States of AmericaA1
IL298330B1IsraelB1
US12264345B1United States of AmericaB1
Showing 100 of 107